GGrantIndex
← Leaderboards

Mark Goodarzi

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center

$8,044,644
Attributed
$14,254,058
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,254,058 · 9

By mechanism

U01$7,508,843 · 2
R01$6,562,658 · 3
P30$147,038 · 1
M01$35,519 · 3

Top collaborators

Others in their field

Top investigators on “Diabetes Mellitus

Research focus

Diabetes MellitusRisk FactorsNon-Insulin-Dependent Diabetes MellitusResearch PersonnelResponseFunctional DisorderPhenotypeSamplingInsulinInsulin ResistanceGlucoseBaseInsulin SecretionPreventPreventionAcute PancreatitisPancreatitisInnovationChronic PancreatitisPublic HealthRecurrenceDesignRecruitNational Institute Of Diabetes And Digestive And Kidney Diseases

Grant awards (41)

Cedars Sinai Center for the Chronic Pancreatitis Clinical Research Consortium$574,090
U01 · FY2025 · DK
Cedars Sinai Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium$511,000
U01 · FY2025 · DK · contact PI
Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer$416,077
U01 · FY2024 · DK
Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium$283,999
U01 · FY2024 · DK · contact PI
Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer$362,252
U01 · FY2023 · DK
Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium$285,093
U01 · FY2023 · DK · contact PI
Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer$507,104
U01 · FY2022 · DK
Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium$286,658
U01 · FY2022 · DK · contact PI
Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer$110,976
U01 · FY2022 · DK
Impact of the gut microbiome and diet on change in insulin homeostasis and cardiometabolic risk$541,829
R01 · FY2021 · DK · contact PI
Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer$506,974
U01 · FY2021 · DK
Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium$311,024
U01 · FY2021 · DK · contact PI
Impact of the gut microbiome and diet on change in insulin homeostasis and cardiometabolic risk$583,364
R01 · FY2020 · DK · contact PI
Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer$523,936
U01 · FY2020 · DK
Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium$324,613
U01 · FY2020 · DK · contact PI
Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer$90,342
U01 · FY2020 · DK
Impact of the gut microbiome and diet on change in insulin homeostasis and cardiometabolic risk$597,787
R01 · FY2019 · DK · contact PI
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes$429,528
U01 · FY2019 · DK
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes - Administrative Supplement$220,763
U01 · FY2019 · DK
Human Genetics$73,116
P30 · FY2019 · DK · contact PI
Impact of the gut microbiome and diet on change in insulin homeostasis and cardiometabolic risk$626,334
R01 · FY2018 · DK · contact PI
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes$425,569
U01 · FY2018 · DK
Improving beta-cell function in Mexican American women with prediabetes$330,161
R01 · FY2018 · MD
Human Genetics$73,922
P30 · FY2018 · DK · contact PI
Impact of the gut microbiome and diet on change in insulin homeostasis and cardiometabolic risk$731,833
R01 · FY2017 · DK · contact PI
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes$445,753
U01 · FY2017 · DK
Improving beta-cell function in Mexican American women with prediabetes$359,326
R01 · FY2017 · MD
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes$459,262
U01 · FY2016 · DK
Improving beta-cell function in Mexican American women with prediabetes$375,670
R01 · FY2016 · MD
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes$433,830
U01 · FY2015 · DK
Improving beta-cell function in Mexican American women with prediabetes$373,495
R01 · FY2015 · MD
Improving beta-cell function in Mexican American women with prediabetes$390,187
R01 · FY2014 · MD
Insulin Clearance: Candidate and Positional Genetic Determinants$318,533
R01 · FY2012 · DK · contact PI
Insulin Clearance: Candidate and Positional Genetic Determinants$318,533
R01 · FY2011 · DK · contact PI
Insulin Clearance: Candidate and Positional Genetic Determinants$321,750
R01 · FY2010 · DK · contact PI
Insulin Clearance: Candidate and Positional Genetic Determinants$68,231
R01 · FY2010 · DK · contact PI
Insulin Clearance: Candidate and Positional Genetic Determinants$325,000
R01 · FY2009 · DK · contact PI
Insulin Clearance: Candidate and Positional Genetic Determinants$300,625
R01 · FY2008 · DK · contact PI
CLINICAL TRIAL: PHARMACOGENETICS OF INSULIN RESISTANCE IN PCOS$30,700
M01 · FY2008 · RR · contact PI
PILOT STUDY IN PHYSIOLOGIC QUANTIFICATION OF INSULIN - RELATED TRAITS$1,079
M01 · FY2007 · RR · contact PI
PILOT STUDY IN PHYSIOLOGIC QUANTIFICATION OF INSULIN - RELATED TRAITS$3,740
M01 · FY2006 · RR · contact PI